Loading...
XSHG
600613
Market cap465mUSD
Dec 05, Last price  
6.86CNY
1D
-1.29%
1Q
3.00%
Jan 2017
-51.10%
Name

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd

Chart & Performance

D1W1MN
XSHG:600613 chart
P/E
46.06
P/S
1.60
EPS
0.15
Div Yield, %
1.46%
Shrs. gr., 5y
0.91%
Rev. gr., 5y
1.23%
Revenues
2.05b
-12.48%
69,835,17762,362,02065,958,55169,622,28676,975,441105,841,382148,250,092153,999,261929,184,1501,293,713,3301,592,912,4881,597,867,9211,735,715,9551,852,905,9511,927,593,2141,819,006,6912,303,032,7192,388,617,6772,340,945,5182,048,808,450
Net income
71m
+25.24%
7,780,3032,891,11213,790,5354,384,43405,674,00317,554,36513,701,765111,540,028180,170,055216,730,448182,059,820129,601,273106,091,39083,974,764069,622,53748,548,12157,000,67471,388,047
CFO
208m
-3.62%
32,719,702016,007,52125,264,7037,690,62733,035,3810074,749,395030,117,673570,41366,987,417148,525,997128,279,88899,097,235184,263,469319,232,403215,590,355207,785,516
Dividend
Jun 18, 20240.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, tonic products, cold and cough, children's medicine, and anti-fungal drugs. Its products include prescription drugs and OTC products. The company was founded in 1992 and is based in Shanghai, China.
IPO date
Aug 20, 1992
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT